Actively Recruiting
Study of Antiepileptic Drug Use, Safety, and Effectiveness in People Aged 65 to 100 with Epilepsy
Led by Wei Zhao · Updated on 2022-07-15
500
Participants Needed
1
Research Sites
13 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are studying elderly patients aged 65 to 100 years who have epilepsy to understand how antiepileptic drugs like phenytoin, carbamazepine, lamotrigine, levetiracetam, and perampanel behave in the body. The study aims to evaluate how effective and safe these drugs are in this population and to recommend optimized dosage plans. Participants receive antiepileptic drugs as part of their routine treatment, with the specific drug choice depending on clinical practice. This observational study monitors patients without altering their treatment but collects detailed information on drug levels and effects. During the study, researchers measure drug concentrations at different times after oral administration to track how the medication is processed. They also record any adverse drug reactions and seizure frequency over an average period of 14 days. The study started in 2021 and will continue through June 2028, involving ongoing assessments to better understand treatment outcomes in elderly patients with epilepsy.
CONDITIONS
Brief Title
Antiepileptic Drugs in Elderly Patients
Research Team
W
Wei Zhao
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
